Medin induces pro-inflammatory activation of human brain vascular smooth muscle cells.

Physiol Rep · 2025 · PMC12159308 · PMID 40501029

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Co‐treatment of medin with RO106‐9920 in VSMCs showed a trend (not statistically significant) towards reduced IL‐6, IL‐8, and MCP‐1 gene expression versus medin treatment (Figure 3a–c ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.